181 related articles for article (PubMed ID: 28045974)
21. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
Soboll G; Breathnach CC; Kydd JH; Hussey SB; Mealey RM; Lunn DP
Vet Immunol Immunopathol; 2010 May; 135(1-2):108-117. PubMed ID: 20018383
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
[TBL] [Abstract][Full Text] [Related]
23. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
[TBL] [Abstract][Full Text] [Related]
24. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
[TBL] [Abstract][Full Text] [Related]
25. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
26. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
[TBL] [Abstract][Full Text] [Related]
27. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.
Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140
[TBL] [Abstract][Full Text] [Related]
28. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
Fitzpatrick DR; Studdert MJ
Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
[TBL] [Abstract][Full Text] [Related]
30. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus 1 and equine herpesvirus 4 vaccine.
Foote CE; Love DN; Gilkerson JR; Whalley JM
Vet Microbiol; 2002 Aug; 88(1):13-25. PubMed ID: 12119135
[TBL] [Abstract][Full Text] [Related]
31. Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.
Ellis JA; Steeves E; Wright AK; Bogdan JR; Davis WC; Kanara EW; Haines DM
Vet Immunol Immunopathol; 1997 Jul; 57(3-4):201-14. PubMed ID: 9261959
[TBL] [Abstract][Full Text] [Related]
32. Immune and Inflammatory Response in Horse Vaccinated Against Equine Herpesviruses 1 (EHV-1) and 4 (EHV-4) Assessed by Serum Protein Electrophoretic Pattern and Leukocyte Population.
Giannetto C; Giudice E; Piccione G; Castronovo C; Arfuso F
J Equine Vet Sci; 2022 Sep; 116():104051. PubMed ID: 35753636
[TBL] [Abstract][Full Text] [Related]
33. Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain.
TSUJIMURA K; SHIOSE T; YAMANAKA T; NEMOTO M; KONDO T; MATSUMURA T
J Vet Med Sci; 2009 Nov; 71(11):1439-48. PubMed ID: 19959893
[TBL] [Abstract][Full Text] [Related]
34. TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection.
Zhao Y; Chang J; Zhang B; Tong P; Wang C; Ran D; Su Y
Arch Virol; 2019 May; 164(5):1371-1382. PubMed ID: 30888564
[TBL] [Abstract][Full Text] [Related]
35. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
[TBL] [Abstract][Full Text] [Related]
36. Clinical, serological and molecular investigations of EHV-1 and EHV-4 in 15 unweaned thoroughbred foals.
Marenzoni ML; Passamonti F; Cappelli K; Veronesi F; Capomaccio S; Supplizi AV; Valente C; Autorino G; Coletti M
Vet Rec; 2008 Mar; 162(11):337-41. PubMed ID: 18344498
[TBL] [Abstract][Full Text] [Related]
37. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of vaccination against equine herpesvirus type 1 (EHV-1) infection: Systematic review and meta-analysis of randomised controlled challenge trials.
Marenzoni ML; De Waure C; Timoney PJ
Equine Vet J; 2023 May; 55(3):389-404. PubMed ID: 35946376
[TBL] [Abstract][Full Text] [Related]
39. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
Kydd JH; Townsend HG; Hannant D
Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
[TBL] [Abstract][Full Text] [Related]
40. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
Foote CE; Love DN; Gilkerson JR; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):41-6. PubMed ID: 16513181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
